《Swiss Medical Weekly》雜志的最新年發文量為100篇。
這表明該刊在每年都會精選并發表一定數量的高質量文章，以保持其在醫學：內科領域的學術影響力。
該刊聚焦于醫學-醫學：內科領域的前沿研究，致力于推動該領域新技術和新知識的傳播與應用。同時它積極鼓勵研究人員詳細發表其高質量的實驗研究和理論成果。
該刊的平均審稿周期約為 一般,3-8周 。
Swiss Medical Weekly 雜志發文統計
文章名稱引用次數
- Trends in influenza vaccination uptake in Switzerland: Swiss Health Survey 2007 and 201210
- Vascular endothelial growth factor biology for regenerative angiogenesis8
- Clinical outcomes in patients with systemic lupus erythematosus treated with belimumab in clinical practice settings: a retrospective analysis of results from the OBSErve study in Switzerland8
- Dual use in the 21st century: emerging risks and global governance8
- A digitally facilitated citizen-science driven approach accelerates participant recruitment and increases study population diversity7
- Digital health: meeting the ethical and policy challenges7
- Awareness, approval and completion of advance directives in older adults in Switzerland6
- New insights into the pathophysiology of inflammatory bowel disease: microbiota, epigenetics and common signalling pathways6
- Immunotherapy in head and neck cancer - scientific rationale, current treatment options and future directions6
- The implementation and first insights of the French-speaking Swiss programme for monitoring self-harm5
國家/地區發文量
- Switzerland2626
- USA208
- GERMANY (FED REP GER)185
- France113
- England110
- Italy79
- Belgium62
- Canada56
- Australia49
- Netherlands47
